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ABSTRACT
Little is known about whether components of the
RNA-induced silencing complex (RISC) mediate the
biogenesis of RNAs other than miRNA. Here, we
show that depletion of key proteins of the RISC
pathway by antisense oligonucleotides significantly
impairs pre-rRNA processing in human cells. In cells
depleted of Drosha or Dicer, different precursors to
5.8S rRNA strongly accumulated, without affecting
normal endonucleolytic cleavages. Moderate yet
distinct processing defects were also observed
in Ago2-depleted cells. Physical links between
pre-rRNA and these proteins were identified by co-
immunoprecipitation analyses. Interestingly, simul-
taneous depletion of Dicer and Drosha led to a
different processing defect, causing slower produc-
tion of 28S rRNA and its precursor. Both Dicer and
Ago2 were detected in the nuclear fraction, and
reduction of Dicer altered the structure of the nucle-
olus, where pre-rRNA processing occurs. Together,
these results suggest that Drosha and Dicer are
implicated in rRNA biogenesis.
INTRODUCTION
Drosha and Dicer are RNase III family endonucleases
required for miRNA maturation. In mammalian cells,
miRNA genes are initially transcribed as mono- or
polycistronic precursors (pri-miRNA). The pri-miRNAs
are processed in the nucleus by microprocessor, a
protein complex containing Drosha, to create 60–70nt
pre-miRNAs. Pre-miRNAs are then exported to the cyto-
plasm, where they are processed by the cytoplasmic
protein, Dicer, into 21–24nt miRNAs (1–4). Finally,
miRNAs are incorporated into RNA-induced silencing
complex (RISC) that contains Ago2, another endonucle-
ase. The RISC complex mediates gene expression by either
down-regulating mRNA levels or modulating mRNA
translation (3,5).
The roles of Drosha and Dicer in miRNA biogenesis
have been well studied; however, little is known about
whether these RNase III enzymes participate in the bio-
genesis of other types of RNAs, in addition to miRNAs.
Our group has previously shown that in human cells
Drosha is required for processing of pre-ribosomal RNA
(pre-rRNA), especially for maturation of 5.8S rRNA (6).
This ﬁnding was further conﬁrmed by a later study per-
formed in mouse cells demonstrating that down-
regulation of Drosha or Drosha-associated RNA helicases
(P68 and P72) by siRNA signiﬁcantly reduced the level of
5.8S rRNA (7). These observations prompted us to
explore in more detail the potential roles of protein com-
ponents in the RISC pathway in pre-rRNA processing.
In eukaryotes, 18S, 5.8S and 28S rRNAs are transcribed
by RNA polymerase I into a polycistronic molecule. This
precursor is sequentially processed in the nucleolus (and
nucleus) by multiple steps of endonucleolytic cleavage and
exonucleolytic trimming reactions to produce mature
rRNAs (8–10). In vertebrates, the longest detectable tran-
script, a 47S pre-rRNA containing the three rRNAs, 50
and 30 external transcribed spacers (ETS), and two
internal transcribed spacers (ITS1 and ITS2), is processed
by two alternative pathways to separate small and large
subunit rRNAs (Figure 1A).
Maturation of 5.8S rRNA is one of the most
complicated pre-rRNA processing events. In yeast, the
50-end of 5.8S rRNA is formed by two pathways. The
major pathway involves endonucleolytic cleavage within
ITS1, followed by 50!30 trimming (by Rat1 and Xrn1) to
generate a shorter form of 5.8S rRNA (5.8S-S) (8,11). In a
minor pathway, endonucleolytic cleavage occurs adjacent
to the ‘normal’ 50-end of 5.8S rRNA, to produce a longer
form of rRNA containing additional 7nt at its 50-end
(5.8S-L) (12). In vertebrates, two forms of 5.8S rRNA
(5.8S-S and 5.8S-L) also co-exist (10), suggesting that
the pathway(s) for 50-end formation is consistent with
the yeast model. In rat, cleavage was mapped to  160nt
upstream to the 50-end of 5.8S rRNA. However, no
cleavage sites within ITS1 corresponding to the yeast A2
and A3 sites have been mapped in human cells, and it was
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external and internal transcribed spacers, respectively. The position of the hybridization probe used in (D and E) is shown as a solid bar above 47S
pre-rRNA. (B) mRNA levels were dramatically reduced 48h after treatment with 50nM ASOs targeting Drosha (ISIS25690), Ago2 (ISIS136764) or
Dicer (ISIS138648), as determined by qRT–PCR. The error bars indicate standard deviation from two independent experiments with three replicates.
UTC, untreated cells;+ASO, cells treated with ASOs. (C) The levels of targeted proteins were signiﬁcantly reduced by ASO treatment, as determined
by western analysis. Alpha-tubulin was used as a control for loading. (D) Northern hybridization for pre-rRNA species using a probe speciﬁc to the
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(10).
The 30-end formation of yeast 5.8S rRNA is initiated by
an endonuclease cleavage within ITS2, followed by 30!50
trimming performed by exosome (8,9). In mammals, the
30-end maturation probably involves at least two endo-
nucleolytic cleavages, as two 5.8S rRNA precursors con-
taining  156 or  250nt of ITS2 sequence have been
detected in human cells (13). As in yeast, 30-end formation
ofthevertebrate5.8SrRNAalsorequirestheexosome(14).
Although pre-rRNA undergoes multiple endonucleo-
lytic cleavages, the endonucleases responsible for each
cleavage reaction are still largely unknown. In yeast, it
has been shown that the endonuclease MRP complex is
required for cleavage at site A3 within ITS1, whereas
Rnt1, an RNase III protein, is required for the cleavage
at 30 ETS (8,9,15). The observation that the RNase III
protein, Drosha, is required for 5.8S rRNA processing
in mammals (6) raises an interesting possibility that
another RNase III protein in the RISC pathway, Dicer,
or even the RISC pathway itself, may also be involved in
rRNA maturation. Indeed, in this study, we show that
reduction of Dicer or Drosha or both in HeLa cells
causes strong accumulation of aberrant precursors for
5.8S rRNA and signiﬁcantly reduces the processing rate
of 28S rRNA. Depletion of Ago2, the core protein in the
RISC complex, also leads to moderate pre-rRNA process-
ing defects that are distinct from those caused by loss of
Dicer or Drosha. Our data suggest that Drosha and Dicer
are implicated in pre-rRNA processing, in a manner most
likely unrelated to the RISC pathway. However, the RISC
pathway may also be involved in the maturation of
pre-rRNA. Consistent with the observations that these
proteins affect pre-rRNA processing, nuclear localization
of Dicer and Ago2 is shown.
MATERIALS AND METHODS
Antibodies
Anti-Dicer (ab14601), anti-Ago2 (ab57113), anti-hnRNP
A2 (ab6102), anti-GAPDH (ab8245) and anti-nucleolin
(ab22758) antibodies were purchased from Abcam. Anti-
SF3B3 antibody (SC-21324) was from Santa Cruz
Biotechnology. Anti-a tubulin antibody (T-5168) was
from Sigma. Anti-Drosha antibody was raised in rabbit
using synthetic peptide (amino acids 266–284), as
described previously (6). Anti-rabbit secondary antibody
conjugated to Texas Red (ab6719) and anti-mouse
antibody conjugated to FITC (ab6785) were purchased
from Abcam.
Antisense oligonucleotides
Synthesis and puriﬁcation of phosphorothioate/
20-methoxylethyl (20MOE) oligonucleotides were carried
out as described previously (16). The sequences of
20-MOE ASOs, or oligonucleotides used for northern hy-
bridization, primer extension, and RT–PCR are listed in
Supplementary Data.
Cell culture and transfection
HeLa cells were grown on plates in DMEM medium
supplemented with 10% fetal calf serum (FCS) and 1%
penicillin/streptomycin at 37 Ci n5 %C O 2 incubator. For
knock-down of targeted genes, sub-conﬂuent cells were
treated with ASOs at 50nM ﬁnal concentration in
Opti-MEM medium containing 4mg/ml Lipofectamine
2000 (Invitrogen) for 4h. Cells were harvested 48h after
transfection. For double knock-down, the second ASO
was transfected 24h after ﬁrst transfection, and cells
were harvested 30h later.
RNA preparation and manipulation
Forty-eight hours after ASO transfection, cells were
washed once with PBS, and RNA prepared directly
from culture dishes using Tri-Reagent (Sigma), based on
manufacturer’s instruction. Northern analysis was per-
formed as described previously (17). Primer extension
was carried out essentially as in Ref. (18), except that ex-
tension reactions were performed at 45 C for 1h. Reverse
transcription–PCR and quantitative real-time PCR (qRT–
PCR) were performed as described in Supplementary
Data.
Sub-cellular fractionation
Cytoplasmic and nuclear fractions were separated from
 5 10
7 cells using Nuclear Extract Kit (Qiagen), follow-
ing the manufacturer’s instruction. Five percent of cyto-
plasmic and 20% of nuclear fractions were separated by
SDS–PAGE for western analysis.
Immunoprecipitation
Whole cell extracts prepared in Buffer A [25mM Tris–Cl
pH 8.0; 5mM MgCl2; 150mM KCl; 10% glycerol;
0.5mM PMSF; 5mM b-mercaptoethanol; and one tablet
of Protease Inhibitor Cocktail/50ml (Roche)] were
incubated at 4 C for 4h with Protein A beads (Roche)
pre-coated with antibodies against Drosha, Dicer or
Ago2. After seven washes with wash buffer (50mM
Tris–Cl, pH 7.5; 150mM NaCl; 5mM EDTA; 0.1%
NP-40; 0.05% SDS), the co-selected RNAs were
prepared directly from the beads using Tri-Reagent.
Figure 1. Continued
boundary of 5.8S rRNA/ITS2. Total RNA prepared from test cells 48h after ASO treatment was separated on a 1.2% agarose gel, and the blot was
subjected to hybridization. The arrows indicate precursors to 5.8S rRNA. The positions of mature rRNAs are indicated. Lower panel shows ethidium
bromide staining of rRNAs in the same gel. (E) Pre-5.8S rRNA accumulated in cells depleted of Drosha, Ago2 or Dicer. Total RNA as used in (C)
was separated in an 8% polyacrylamide, 7M urea gel and the blot was hybridized using the same probe as in (D). The arrows indicate different
pre-5.8S rRNA species (marked as A, B and C). U3 snoRNA was probed to serve as a loading control. Lower panel shows ethidium bromide
staining of rRNAs in the same gel.
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Cells grown in 6-well dishes were pre-incubated with
serum-free, methionine-free medium at 37 C for 30min,
followed by incubation for 30min in 1.5ml of the same
medium containing 75mCi L-[methyl-
3H] methionine
(Perkin-Elmer). The cells were then chased in the same
medium containing 30mg/ml unlabeled methionine for 0,
30, 60 or 90min. Next, total RNA was isolated using Tri-
Reagent, separated on a 1.2% agarose gel, and transferred
to nylon membrane. The membrane was sprayed with
Enhance Spray (Perkin-Elmer), and exposed to X-ray
ﬁlm.
Western analysis and immunoﬂuorescence
Western analysis was performed as described in
Supplementary Data. For immunoﬂuorescence, cells
grown in Glass Bottom Culture Dishes (MatTek) were
washed twice with 1  PBS, ﬁxed with 4% formaldehyde
in PBS for 30min at room temperature, and permeabilized
for 5min using 0.15% Triton X-100 in PBS. Following
three washes with 1  PBS, cells were treated with
blocking buffer (1mg/ml BSA in 1  PBS) at RT for
30min, and incubated with ﬁrst antibodies for Nucleolin
(ab22758, 1:150, Abcam), Dicer (ab14601, 1:200, Abcam)
or Ago2 (ab57113, 1:200, Abcam) at 4 C for ON, or at
room temperature for 3 h. After three washes with wash
buffer (0.1% NP-40 in 1  PBS), cells were incubated with
secondary antibodies (1:200) in blocking buffer at RT for
2h, and washed three times with wash buffer. For double
staining (Figure 7), two antibodies were used together, as
indicated in ﬁgure legends. Finally, cells were mounted
using Prolong Gold anti-fade reagent with DAPI
(Invitrogen) and covered. Image was taken using a
confocal microscopy (Olympus) and analyzed with
Fluoview Ver. 2.0b Viewer (Olympus).
RESULTS
Depletion of Dicer or Drosha leads to strong
accumulation of 5.8S rRNA precursors
TodeterminethepotentialinvolvementofDicerandDrosha
in pre-rRNA processing, HeLa cells were treated for 48h
with RNase H-dependent, chimeric phosphorothioate/
20-O-methyloxylethyl modiﬁed antisense oligonucleotides
(ASOs) targeting the mRNAs of these two proteins, as
previously described (16,19). Ago2 mRNA was also
targeted to examine if the RISC pathway is involved.
As expected, ASO treatment resulted in  90% reduction
in the levels of Drosha and Ago2 mRNAs, and  75%
reduction for the Dicer mRNA, as determined using
qRT–PCR (Figure 1B). The levels of corresponding
proteins were also dramatically reduced, as detected by
western analysis (Figure 1C).
The effect of depleting the targeted proteins on
pre-rRNA processing was analyzed by northern hybrid-
ization, using oligonucleotide probes complementary to
different regions of the pre-rRNA. Signiﬁcant accumula-
tion of low molecular weight pre-rRNAs was found in
cells depleted of Drosha, Dicer or Ago2 (Figure 1D), as
determined using a probe complementary to the boundary
of 5.8S rRNA and ITS2. This probe recognizes pre-rRNA
species containing both 5.8S rRNA and the ITS2
sequence, including the known 47S, 45S, 32S and 12S
pre-rRNAs. 47S and 45S pre-rRNA were not detected in
this experiment, due to their low abundance, but 47S
pre-rRNA was detected in other experiments with no sig-
niﬁcant accumulation in the treated cells, similar to 32S
pre-rRNA (data not shown). No signiﬁcant changes in the
levels of mature rRNAs and other pre-rRNAs were
observed (Figure 1D and E; and data not shown). These
results suggest that depletion of Drosha, Dicer or Ago2
impairs pre-rRNA processing at a late stage, most likely at
the stage of 5.8S rRNA maturation (Figure 1A).
To conﬁrm the defects on 5.8S rRNA maturation with
higher resolution, total RNA was separated by polyacryl-
amide gel electrophoresis, and pre-5.8S rRNA species
were detected using the same probe as in Figure 1D.
Indeed, a precursor (band C) in the size of  300nt was
found to be strongly accumulated, with  350%,  110%
and  230% increase in cells lacking Drosha, Ago2 or
Dicer, respectively, as compared with control cells.
Another larger precursor (band B region,  400nt) was
detected in all cells, but appeared to accumulate moder-
ately in Drosha or Dicer-depleted cells. In addition, at
least one aberrant precursor (band A,  500nt) was
observed in cells depleted of Drosha or Dicer, but not
detected in control or Ago2-depleted cells. These results
suggest that reduction of Ago2 caused either a different
phenotype or less severe defects on pre-rRNA processing
than loss of Drosha or Dicer.
Although ribosome production is well regulated in
response to physiological conditions (20), the observed
defects on pre-rRNA processing are not due to a non-
speciﬁc cellular response to transfection of ASOs, nor
due to off-target activities of the ASOs that unexpectedly
down-regulate the expression of other genes . Evidence
includes: (i) transfection of several non-relevant control
ASOs had no effect on the level of pre-5.8S rRNA
(Supplementary Figure S1 and dada not shown); (ii),
transfection of other ASOs targeting different regions of
Drosha, Dicer or Ago2 mRNA caused similar defects on
5.8S rRNA processing (Supplementary Figure S2); and
(iii) accumulation of pre-5.8S rRNA strongly correlates
with the extent and the kinetics of depletion of the targeted
genes (Supplementary Figures S3–S6). For example,
pre-5.8S rRNA had already signiﬁcantly accumulated
24h after ASO treatment, correlating with the time
when the target proteins were dramatically reduced
(Supplementary Figures S3–S5). In addition, the weaker
accumulation of pre-5.8S rRNA in Ago2-depleted cells is
not due to potential compensatory effects of other Ago
proteins, since depletion of Ago1, Ago3 or Ago4 alone did
not result in accumulation of pre-5.8S rRNA, and
co-depletion of Ago2 and either one of the other three
Ago proteins did not increase the level of pre-5.8S
rRNA beyond that caused by depletion of Ago2 alone
(Supplementary Figure S7). Finally, the processing
defect is not due to impaired biogenesis of processing
small nucleolar RNAs (snoRNAs) caused by depletion
of these endonucleases, since the levels of the snoRNAs
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U3, U14, U17, U8, U22 and MRP RNA (21), were not
affected (data not shown). Taken together, these data
suggest that depletion of Dicer, Drosha or Ago2 impairs
pre-rRNA processing, albeit to different extents.
Different pre-5.8S rRNA species accumulate in cells
depleted of the RISC pathway proteins
All the pre-5.8S rRNA species detected in Figure 1 contain
30 extensions, since the hybridization probe recognizes
only this subset of pre-rRNAs. The two major bands
( 300 and  400nt) are identical in size to the two previ-
ously reported precursors, which contain mature 50-end of
5.8S rRNA and 30 extensions with  156 or  250nt ITS2
sequence, respectively (13,22). These data suggest that the
two precursors we detected here also contain only the 30
extensions. To conﬁrm this, and to determine if loss of
these proteins leads to accumulation of precursors con-
taining 50 extension, high resolution northern hybridiza-
tion was performed using probes speciﬁc to 5.8S rRNA
(5.8S), or the 50, or the 30 boundaries of the 5.8S rRNA
(Figure 2A). The 50 or 30 probes recognize precursors con-
taining ITS1 sequence at 50-end of 5.8S rRNA, or ITS2
sequence at 30-end of 5.8S rRNA, respectively. However,
the 5.8S probe can detect precursors containing either 50
or 30 extension, or both.
For convenience, the detected RNA species were named
and labeled. Again, when the 30 probe was used
(Figure 2B, right panel), strong accumulation of the
300nt precursor was detected in Drosha- or Dicer-
depleted cells, and moderate accumulation in Ago2-
depleted cells. At least eight bands were detected with
the 30 probe, namely band A ( 500nt), B ( 420nt), B0
( 400nt), C ( 300nt), D ( 290nt), one larger ( 340nt)
and two shorter bands ( 170nt). The latter three
(indicated by asterisks) were only detected with the 30
probe but not with 5.8S probe, suggesting that these
bands are the result of non-speciﬁc hybridization or rep-
resent pre-rRNA species lacking 5.8S rRNA sequence
complementary to the 5.8S probe, thus we eliminate
them from further discussion.
When the 5.8S probe was used (Figure 2B, middle
panel), the bands (B–D) were again detected. Band A
was not visible here but was detected in other experiments
(data not shown). In addition to 5.8S rRNA, three new
products (bands E, F and G) were detected to be strongly
increased in Drosha- or Dicer-depleted cells that were not
identiﬁed with the 30 probe. This observation indicates
that these three precursors do not contain 30 extensions,
but have 50 extensions. Indeed, when the 50 probe was used
(Figure 2B, left panel), the three bands were clearly
detected and were enriched in Drosha- or Dicer-depleted
cells, but band E and F were not enriched in
Ago2-depleted cells. These data indicate that depletion
of these proteins causes accumulation of different 5.8S
rRNA precursors with either 50 or 30 extensions, or both.
However, the level of mature 5.8S or 5.8S-L rRNA was
not signiﬁcantly affected (Figures 1E and 2B, left panel),
suggesting that processing was not fully blocked.
For comparison, the hybridization results are
summarized in Figure 2C. Band A contains both 50 and
30 extensions and was accumulated only in Drosha- or
Dicer-depleted cells. Band B contains both 50 and 30 ex-
tensions, as it was detected by both 50 and 30 probes. Band
B0 contains only a 30 extension, since it was detected by
either the 30 or the 5.8S probe in all cells, but not by the 50
probe. The most accumulated product, band C, appears to
contain two different RNA species. One (C0) contains only
a3 0 extension but not a 50 extension, since no RNA was
detected in Ago2-depleted cells using the 50 probe at this
position (Figure 2B, middle and right panels), but a
product was readily found using either the 30 probe or
the 5.8S probe. However, the 50 probe detected a
product at this position (band C) in Drosha- or
Dicer-depleted cells, indicating that band C has a 50 ex-
tension, with or without a 30 extension. Product D, which
slightly increased in cells depleted of these proteins,
contains only a 30 extension. Finally, two pre-rRNAs,
bands E and F, contain 50 but not 30 extensions and
accumulated only in cells lacking Dicer or Drosha. Band
G, which has only a 50 extension, was strongly increased in
Drosha- or Dicer-depleted cells and moderately increased
in Ago 2-depleted cells. The detection of products contain-
ing 50 extension (bands E, F and G) in control cells indi-
cates that in normal processing pathway, endonucleolytic
cleavage occurs upstream to the 50-end of 5.8S rRNA, as is
the case in yeast (10). Together, these results indicate that
depletion of these proteins impairs processing of pre-5.8S
rRNA, causing accumulation of abnormal intermediates.
Ago2 reduction causes moderate accumulation of precur-
sors mainly with a 30 extension, whereas depletion of
Drosha or Dicer leads to accumulation of precursors
with extensions at either 50-o r3 0-end, or both ends, but
preferentially with 50 extensions. Although reducing either
Drosha or Dicer results in similar defects, certain differ-
ence does exist. For example, band E is much more
abundant in Dicer-reduced cells than in Drosha-reduced
cells.
Depletion of Drosha or Dicer does not block normal
endonucleolytic cleavages for production of 5.8S rRNA
The accumulation of abnormal pre-5.8S rRNA species in
Dicer- or Drosha-depleted cells may stem from impaired
exonucleolytic trimming, or from impaired
endonucleolytic cleavage events. Two endonucleolytic
cleavage sites within ITS1 (A2 and A3) region have been
identiﬁed in yeast, however, no such sites have been
mapped in human cells. In addition, two processing inter-
mediates have been detected in human cells that contain
the mature 50-end of 5.8S rRNA and  156 and  250nt of
ITS2 sequence, respectively (13), yet it is not known if
these products are generated from endonucleolytic
cleavage or exonucleolytic trimming. To identify potential
cleavage events in ITS regions and to determine if deple-
tion of Dicer or Drosha impairs endonucleolytic cleav-
ages, primer extension was performed using six different
primers speciﬁc to ITS1 or ITS2 regions (Figure 3A). Two
major extension stops were detected in control cells using
probe 2 located in the junction of ITS1/5.8S rRNA,
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rRNA coding region with 109–110nt or 152–153nt of
ITS1 sequence, respectively (Figure 3B). No strong exten-
sion stop was detected further upstream using probe 1
(data not shown). The two extension stops may represent
structural stops in the primer extension assay. However,
this seems unlikely, since most other weaker extension
stops, upstream or downstream, exhibited comparable
signal strength in control and Dicer-depleted cells,
whereas these two stops appear stronger in Dicer-
depleted cells. Thus, these two products may stem from
direct endonucleolytic cleavage at these positions, or from
50!30 trimming of precursors cleaved somewhere
upstream. Despite this uncertainty, it is clear that
endonucleolytic cleavage occurs within ITS1 sequence
either at or upstream to these positions. Signiﬁcantly
Figure 2. Loss of RISC proteins leads to accumulation of different pre-5.8S rRNA species. (A) Depiction of probe positions around the 5.8S rRNA
region. The probe names are shown under the pre-rRNA. (B) Total RNA was prepared from test cells 48h after ASO treatment, and subjected to
northern hybridization. The same membrane was hybridized sequentially using probes speciﬁc to 50 (left panel, 50 probe), 5.8S (middle panel, 5.8S
probe) and 30 regions (right panel, 30 probe), respectively. U3 snoRNA was used as a loading control. Different pre-5.8S rRNA species are indicated.
The asterisks indicate RNA species that were only detected with one probe. M, size maker in nucleotides (low range ssRNA ladder, Biolabs); 5.8S-L,
the longer version of mature 5.8S rRNA; shorter exposure for 5.8S-L rRNA is shown in left panel, lower part. (C) Summary of changes in the levels
of different pre-5.8S rRNA species in cells depleted of the RISC pathway proteins. App. size, estimated nucleotide length of the RNA. Extension,
types of 50 or 30 ﬂanking sequences in pre-5.8S rRNAs. The larger arrows indicate stronger accumulation.
4880 Nucleic Acids Research, 2011,Vol.39, No. 11Figure 3. Depletion of Dicer or Drosha does not block normal endonucleolytic cleavages in pre-rRNA. (A) Relative positions of primers used in
primer extension assays. The numbered arrows below the pre-rRNA represent the primers. Positions relative to 5.8S rRNA are shown. (B) Primer
extension analysis for ITS1 region using primer 2. The extension products were separated in an 8% sequence gel, next to a primer extension
sequencing ladder performed with a primer speciﬁc to 18S rRNA (XL066). The same sequencing ladder was used for all gels in this ﬁgure. The
calculated distances relative to the 50-end of 5.8S rRNA are given in nucleotides. The solid arrows indicate normal processing products, whereas open
arrows indicate products accumulated only in Dicer- or Drosha-depleted cells. (C) Primer extension for ITS2 regions using primers 5 and 6, as in (B).
The two potential cleavage products are marked by arrows and the distances relative to the 30-end of 5.8S rRNA are shown in nucleotides.
(D and E) Primer extension using primers 3 and 4, respectively. The arrows indicate pre-rRNA species with 50-ends that exist in normal cells,
but accumulated in Dicer- or Drosha-depleted cells. The asterisks indicate extension stops that occurred within the 5.8S rRNA coding regions.
(F) Summary of the mapping data. The solid bars below the pre-rRNA represent positions of primers, as indicated in (A). The potential cleavage
positions in normal cells are marked with downward arrows and the relative distances to 5.8S rRNA are shown. The open arrows indicate 50
positions of pre-rRNAs that accumulated in Dicer-depleted cells, whereas the upward sharp arrows indicate 50 positions of pre-rRNAs that
accumulated in Drosha-depleted cells.
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Dicer-depleted cells, but not in Drosha-depleted cells, sug-
gesting that loss of Dicer or Drosha did not affect the
normal endonucleolytic cleavages within ITS1 regions,
yet downstream processing events are slower in
Dicer-depleted cells, leading to accumulation of precur-
sors containing these 50-ends. Interestingly, two additional
stops ( 120–123 or  138–143nt upstream to the 50-end of
5.8S RNA) in between the two normal extension stops
appeared in Dicer-depleted cells, and to a lesser extent
also in Drosha-depleted cells. This observation indicates
that depletion of Dicer or Drosha causes accumulation of
pre-rRNAs containing an ITS1 sequence with abnormal
50-ends. The accumulation of these precursors is consistent
with the northern hybridization results (Figure 2), which
showed stronger accumulation of pre-5.8S rRNA contain-
ing 50-extensions in Dicer-depleted cells than in
Drosha-depleted cells.
Two signiﬁcant stops were also detected within ITS2
regions, using primers 5 and 6, respectively (Figure 3C).
These two stops were mapped to  144nt and  263nt
downstream from the 30-end of 5.8S rRNA, indicating
that endonucleolytic cleavages occur around these two
regions, since precursors containing 5.8S rRNA and
 156 and  250nt ITS2 sequences have been identiﬁed
previously using a RNase protection assay (13).
However, depletion of Dicer or Drosha did not cause sig-
niﬁcant changes in the signal strength or cleavage pos-
itions, indicating that endonucleolytic cleavages at these
two regions were not affected. Accumulation of precur-
sor(s) containing a mature 50-end of 5.8S rRNA and an
ITS2 sequence was found in Dicer or Drosha-depleted
cells, as determined using primer 3 located 31nt down-
stream to the 30-end of 5.8S rRNA (Figure 3D).
Reduced signal strength was observed in Dicer- or
Drosha-depleted cells for a primer extension stop located
within 5.8S rRNA coding region (indicated by an
asterisk), which may represent either a structural or a
modiﬁcation stop. Accumulation of similar precursor(s)
containing mature 50-end of 5.8S rRNA and ITS2 was
also detected using primer 4 (Figure 3E), consistent with
the northern hybridization results showing accumu-
lation of pre-5.8S rRNA with 30 extension (Figure 2).
Interestingly, a product containing the ITS1 sequence
was accumulated in Drosha-depleted cells, but not in
Dicer-depleted cells (Figure 3E), indicating that depletion
of Drosha or Dicer caused different processing defects.
However, no new extension stop was detected using
primer 4 in cells depleted of Drosha or Dicer. In
addition, the extension stops detected in Figure 3B were
not observed using primers 3 and 4 (Figure D and E),
suggesting that the products may not contain a 30
extension.
The primer extension results were summarized in
Figure 3F. The data suggest that in normal cells, endo-
nucleolytic cleavage occurs within ITS1 and ITS2 regions
in human cells. Depletion of Dicer or Drosha did not
affect endonucleolytic cleavages at normal sites; rather,
downstream processing events of pre-5.8S rRNA
appeared to be impaired, as indicated by the accumulation
of abnormal pre-rRNAs containing various 50-ends.
Simultaneous reduction of Dicer and Drosha leads to
different pre-rRNA processing defects
Reduction of Dicer or Drosha causes similar defects of
pre-5.8S rRNA maturation, without fully blocking
pre-rRNA processing. This observation raises an interest-
ing question: do the two proteins play redundant roles in
pre-rRNA processing? To evaluate this possibility, the two
proteins were depleted simultaneously by transfection of
ASOs targeting the two mRNAs. We reasoned that if the
two proteins play redundant roles, simultaneous loss of
the two proteins should cause a greater defect than what
was observed for a single depletion.
Double depletion caused reduction in the levels of
Drosha and Dicer mRNAs by  85% and 80%, respect-
ively (Figure 4A). However, simultaneous depletion of
Drosha and Dicer signiﬁcantly decreased the elevated
level of pre-5.8S rRNA in response to reduction of a
single protein (Figure 4B). In cells depleted of Drosha or
Dicer alone, pre-5.8S rRNA level increased by  2.5- to
3-fold, whereas only 1-fold increase was found in cells
depleted of the two proteins (Figure 4C). This observation
suggests that depletion of the two proteins either leads to a
different defect, or suppresses the processing defects
caused by single depletion.
To distinguish these possibilities, pre-rRNA processing
was analyzed using in vivo pulse-chase labeling with
[methyl-
3H]methionine, which labels pre-rRNA through
nucleotide methylation during rRNA maturation.
Different precursors (47S, 41S, 32S and 21S) as well as
the newly produced 28S and 18S rRNAs were clearly
detected (Figure 4D). However, the signal for 5.8S
rRNA was extremely low (data not shown), most likely
due to the fact that this RNA contains only a few modiﬁed
nucleotides. In Dicer-depleted cells, maturation of 28S
rRNA was moderately slower than control cells, as
evidenced by lower level of 28S rRNA at time points 30,
60 and 90min after the onset of chase, as compared
with control cells. In cells depleted of both Dicer and
Drosha, maturation of 28S rRNA was much slower,
even than Dicer-depleted cells. However, the level of 32S
pre-rRNA, the common precursor of large subunit
rRNAs (5.8S and 28S), was also lower than control and
Dicer-depleted cells, indicating that accumulation of 32S
pre-rRNA is impaired by depletion of the two proteins.
The difference in signal strength of 32S pre-rRNA is not
due to impaired methylation (labeling) of rRNA, since
the early precursor (47S pre-rRNA) and mature rRNA
(18S rRNA) were normally labeled. No signiﬁcant defect
was found for processing of 28S and 18S rRNA in cells
depleted of Drosha with 50nM ASO as used in this
study (pulse-chase labeling, data not shown), consist-
ent with our previous ﬁnding that depletion of Drosha
using low ASO concentration (75nM) did not cause accu-
mulation of 32S and 12S pre-rRNA, which occurred
with high concentration (150 or 300nM), as observed in
the previous work (6) and current study (data not shown).
These results indicate that the under-accumulation of
32S rRNA in double-depleted cells is due to combined
loss of both proteins. As an internal control, the pro-
cessing rate for 18S rRNA was not impaired in cells
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data suggest that the decrease in the level of pre-5.8S
rRNA in cells depleted of both Dicer and Drosha
stems from reduced production of the upstream precursor
(32S), and that combined depletion of both proteins
caused somewhat different processing defects, with
slower production of 32S pre-rRNA and its downstream
products.
Nucleolar structure is altered in cells lacking Dicer
In eukaryotes, pre-rRNA is transcribed and processed
in the nucleolus, which is a tripartite structure in terms
of known functions. Pre-rRNA is transcribed in the
ﬁbrillar center (FC), and initially processed in a surround-
ing domain known as dense ﬁbrillar center (DFC). Late
processing events occur in a third structure, the granular
component (GC) (23). Certain step(s) of pre-rRNA
processing also occurs in the nucleoplasm (24). Since
loss of Drosha or Dicer affects rRNA processing,
we reasoned that nucleolar structure might be affected
as well. Thus, indirect immunoﬂuorescence was performed
to stain a nucleolar marker protein, Nucleolin, which
localizes in DFC and GC. This protein is also known
to be required for pre-rRNA processing (25). Signiﬁcant
difference in the nucleolar structure was found in cells
depleted of Dicer, which exhibit fewer, but larger,
aggregated nucleoli than control cells (Figure 5). This dif-
ference is signiﬁcant, since  65% of cells treated with
the Dicer ASO contained aggregated nucleoli, whereas
<10% of control cells showed similar nucleolar struc-
tures (data not shown). No signiﬁcant difference in nucle-
olar structure was observed in cells depleted of Ago2
or Drosha, although reduction of Drosha caused pro-
cessing defects similar to depletion of Dicer. Together,
these results indicate that reduction of Dicer alters nucle-
olar structure, directly or indirectly, and that Dicer
and Drosha may affect pre-rRNA processing in different
ways.
Figure 4. Simultaneous depletion of Drosha and Dicer leads to processing defects different from loss of a single protein. (A) mRNA levels in control
cells or in cells depleted of Drosha and Dicer were determined using qRT–PCR, as described in Figure 1. The error bars indicate standard deviation
from three independent experiments. (B) Northern hybridization for pre-5.8S rRNA, as in Figure 1. The arrow indicates the pre-5.8S rRNA product
used for quantiﬁcation in panel C. 5.8S rRNA was detected by ethidium bromide staining. U6 snRNA was used as a loading control. (C) The levels
of pre-5.8S rRNA detected in (B) was normalized to U6 snRNA and plotted. (D) Double depletion of Dicer and Drosha reduced the processing rates
for 32S pre-rRNA and 28S rRNA. In vivo pulse-chase labeling was performed as described in ‘Materials and Methods’ section. Various rRNA
species are indicated. The chase times (in minutes) are given above each lane. The lower panel shows ethidium bromide staining of rRNAs in the
same gel.
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Dicer, Drosha and Ago2 proteins are all required for dif-
ferent steps of the biogenesis or function of the RISC
pathway, which modulates expression of numerous
genes. Thus, the defects on pre-rRNA processing caused
by depletion of these proteins may be a secondary effect.
To address this possibility, we examined if pre-rRNA
could be co-immunoprecipitated with these proteins.
Immunoprecipitation was carried out at 150mM salt
concentration using antibodies against Dicer, Drosha or
Ago2. The co-selection of pre-rRNAs was examined by
RT–PCR. Four sets of primers were used that are
speciﬁc to different regions of pre-rRNA: the boundaries
of 18S rRNA/ITS1 (50ITS1), ITS1/5.8S rRNA (30ITS1),
5.8S rRNA/ITS2 (ITS2) and 28S rRNA/30 ETS (30ETS)
(Figure 6A). A single RT–PCR product speciﬁc to 5.8S/
ITS2 primers was detected at the expected size with the
precipitated RNAs using Drosha, Ago2 or Dicer
antibodies (Figure 6B, upper panel, lanes 3–5), but no
signal was detected in control experiments without
antibody. Similarly, an RT–PCR product speciﬁc to the
junction of ITS1/5.8S rRNA was also detected using
30ITS1 primers (Figure 6C). The relative recovery of the
co-precipitated pre-rRNA was  1–3% of total, as
estimated based on the PCR signal detected with the
RNA sample prepared from 10% of whole-cell extract
used in immunoprecipitation experiment, suggesting
that only a fraction of pre-rRNA is linked with these
proteins. However, neither pre-rRNA(s) containing 18S/
ITS1 or 30 ETS sequence nor b-tubulin mRNA was
detected, as determined using primers speciﬁc to 50ITS1,
30ETS or tubulin mRNA, respectively (Figure 6D and E).
Importantly, the pre-rRNA(s) co-selected with the RISC
proteins were not co-precipitated with an antibody
against splicing factor SF3B3 (Figure 6F), suggesting
that pre-rRNA could be speciﬁcally precipitated with the
RISC pathway proteins. Together, the results suggest that
these proteins are physically linked to pre-rRNA species
containing the 5.8S rRNA and ﬂanking sequences, either
directly or mediated by other components. In addition,
these data also strongly argue that the defect on
pre-rRNA processing is a direct effect caused by loss of
the RISC pathway proteins.
Dicer and Ago2 localize in both the cytoplasm and the
nucleus
It is known that pre-rRNA processing occurs mainly in
the nucleolus, and that later stages of rRNA maturation,
including processing of pre-5.8S rRNA into mature rRNA
in yeast, may occur in the nucleoplasm or even in the
cytoplasm (24,26,27). Drosha localizes in the nucleus
Figure 5. Cells lacking Dicer exhibit altered nucleolar structure. Indirect immunoﬂuorescence was performed for cells depleted of Dicer, Drosha or
Ago2 using ﬁrst antibody against nucleolin and secondary anti-rabbit antibody conjugated to Texas Red (red). DNA was stained with DAPI (blue).
Arrows indicate aggregated nucleoli in cells depleted of Dicer.
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Thus, Drosha and pre-rRNA could co-localize in the
nucleus. However, Dicer and Ago2 are known to be
present predominantly in the cytoplasm (5). The observa-
tion that these two proteins associate with pre-rRNA and
affect pre-rRNA processing raises a possibility that they
may also localize in the nucleus. Indeed, recent studies
showed that Ago2 and Dicer were also detected in the
nucleus by immunoﬂuorescence staining in mammalian
cells (28).
To conﬁrm the nuclear localization of Dicer and Ago2
biochemically, sub-cellular fractionation was performed to
separate cytoplasmic and nuclear proteins, and the
presence of Dicer and Ago2 in these fractions was deter-
mined by western analysis. Dicer was clearly detected in
both cytoplasmic and nuclear fractions (Figure 7A). The
nuclear signal of Dicer is not due to cross contamination
of the fractionation experiment, since a cytoplasmic
protein (alpha-tubulin) and a nuclear protein (hnRNP
A2) were only detected in the corresponding fractions.
Similarly, Ago2 was also clearly detected in both cytoplas-
mic and nuclear fractions, as compared with a cytoplasmic
protein (GAPDH) and a nuclear protein (hnRNP A2),
which were detected only in cytoplasmic and nuclear frac-
tions, respectively (Figure 7B). Although the nuclear
signals of Dicer and Ago2 appears to be higher than the
Figure 6. Pre-rRNA containing 5.8S rRNA and ﬂanking ITS sequences can be co-immunoprecipitated with RISC proteins. Immunoprecipitation
was carried out using antibodies against Drosha, Ago2 or Dicer. Co-selected RNAs were analyzed by RT–PCR. (A) The positions of probe sets in
pre-rRNA used for RT–PCR reaction are indicated. The expected sizes of PCR product are given. Co-immunoprecipitated RNAs were subjected to
reverse transcription with (+RT) or without (–RT) oligonucleotides complementary to different regions of pre-rRNA or tubulin mRNA. RT
reactions were used as templates for PCR ampliﬁcation. The PCR products were analyzed on 2% agarose gels. Input, RNA prepared from 10%
of the material used for immunoprecipitation. –AB, control immunoprecipitation experiment without antibody; M, 1kb plus DNA ladder. The sizes
are shown in base pairs. (B and C) RT–PCR detection for pre-rRNAs containing 5.8S/ITS2 and ITS1/5.8S regions, respectively. (D) RT–PCR for
18S/ITS1 region (upper panel) or 28S/30ETS region (lower panel). (E) RT–PCR for b-tubulin mRNA. (F) Immunoprecipitation was performed using
an antibody against a splicing factor (SF3B3), and the precipitated RNA was subjected to RT–PCR for ITS1/5.8S (30ITS1) or 5.8S/ITS2 (ITS2)
regions.
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levels in the same number of cells, since  20% of nuclear
fraction and  5% of cytoplasmic fraction were loaded for
western analysis.
To examine if Dicer and Ago2 are present in the nucle-
olus where major pre-rRNA processing events occur,
immunoﬂuorescence staining was performed using anti-
bodies against Dicer (Figure 7C, upper panel, green) or
Ago2 (Figure 7C, lower panel, green). Both proteins are
enriched in the cytoplasm, however, weaker but detectable
signal can also be found in the nucleus. No nucleolar
enrichment was found for either protein; instead, it
appears that Ago2 was excluded from the nucleolus,
since the nucleolar signal is weaker than the nucleoplasmic
signal. However, Dicer appears evenly distributed in the
nucleus and nucleolus, suggesting that little amount of
Dicer may be present in this sub-nuclear compartment.
Despite that Dicer and Ago2 were not found to be
enriched in the nucleolus, here we conﬁrmed that both
proteins are present in the nucleus. This is consistent
with the possible involvement of these proteins in pre-
rRNA processing, since maturation of 5.8S rRNA may
occur in the nucleus.
DISCUSSION
In this study, we show that depletion of Drosha or Dicer
impairs pre-rRNA processing. In addition to their roles
in miRNA biogenesis, accumulating evidence suggests
that these proteins may have multiple functions in other
Figure 7. Nuclear localization of Dicer and Ago2. (A) Western analysis of Dicer in cytoplasmic and nuclear fractions. The 5% cytoplasmic and 20%
nuclear fractions prepared from HeLa cells were loaded in a 4–12% SDS–PAGE gel, transferred to a membrane and proteins were detected using
antibodies. Alpha-tubulin and hnRNP A2 were used as controls for cytoplasmic and nuclear proteins, respectively. (B) Ago2 can be found in both
cytoplasmic and nuclear fractions. Western analysis was performed using the same samples as in (C), and the membrane was probed using different
antibodies. GAPDH and hnRNPA2 were detected and used as controls for cytoplasmic and nuclear proteins, respectively. (C) Localization of Dicer
(upper panel) and Ago2 (lower panel) in Hela cells. Cells grown on glass-bottom dishes were ﬁxed, stained with ﬁrst antibodies against Dicer (1:200,
ab14601, from mouse, Abcam) and Nucleolin (1:200, ab22758, from rabbit, Abcam), or against Ago2 (1:150, ab57113, from mouse, Abcam) and
Nucleolin, as described in ‘Materials and Methods’ section. Secondary antibodies were anti-mouse antibody (1:200, ab6785, Abcam, conjugated with
FITC (green) and anti-rabbit antibody (1:200, Ab6719, conjugated with Texas Red). Nucleolin (red) was detected and served as a nucleolar marker.
The nucleus was stained with DAPI (blue). The arrow indicates the positions of nucleoli. The scale bars: 10mm.
4886 Nucleic Acids Research, 2011,Vol.39, No. 11cellular processes, especially in RNA metabolism. The
involvement of Drosha in pre-rRNA processing has
been identiﬁed previously by our group (6). Recent
studies showed that the microprocessor, Drosha/
DGCR8 complex, can cleave the 50 UTR of DGCR8
mRNA, thus negatively regulating DGCR8 expression
(29,30). In addition, small RNAs similar in size to
miRNAs that are derived from abundant non-coding
RNAs, such as rRNA, small nuclear RNA, snoRNA, as
well as tRNAs, are often found in cells (31,32). These
small RNAs are generally considered to be degrad-
ation products; however, a recent study showed that
processing of such a small RNA from a tRNA depends
on Dicer (31). Other studies have also demonstrated
that production of miRNAs derived from snoRNAs
requires Dicer activity (33,34), indicating that Dicer may
be involved in the metabolism of many types of cellular
RNAs. Our ﬁnding that depletion of Drosha or Dicer
impairs pre-rRNA processing suggests new functions for
these versatile RISC pathway proteins. In addition, since
these RISC pathway proteins are not found in budding
yeast, the related pre-rRNA processing events may thus
be different between human and yeast, although major
processing steps are conserved.
The defects in pre-rRNA processing following treat-
ment with Drosha or Dicer ASOs appear to be speciﬁc
to loss of expression of the targeted genes. First, trans-
fection of control ASOs had no effect. Second, different
ASOs targeting the same mRNAs produce similar results,
arguing against the possibility of off-target effects (35).
Third, pre-rRNA can be co-selected with antibodies
against these proteins, providing further evidence of a
direct effect, although it is possible that the association
of pre-rRNA with Ago2 and Dicer is actually mediated
by each other, since these two proteins can be present in
the same RNP complex (36). Finally, we have found that
the levels of known processing snoRNAs were not
changed by depletion of these proteins, arguing against
the possibility that processing defects stem from
impaired snoRNA production. It is unlikely that the pro-
cessing defects caused by loss of Drosha or Dicer are
solely secondary in response to impaired RISC function,
since knockout of DGCR8, a Drosha partner protein
required for miRNA biogenesis, has no effect on pre-
rRNA processing (37). Importantly, we showed that
depletion of Ago2, the core component of functional
RISC complex, caused a different and much weaker pro-
cessing defect than loss of Drosha or Dicer. Although it is
possible that the presence of other Ago proteins (Ago1,
Ago3 and Ago4) may partially compensate for loss of
Ago2, this possibility seems unlikely, since co-depletion
of Ago2 along with one of the other three Ago proteins
did not increase the defects (Supplementary Figure S7).
Together, these observations make it difﬁcult to believe
that the processing defects caused by depletion of Dicer
or Drosha are merely due to impaired miRNA or
snoRNA biogenesis, although we cannot completely rule
out such a possibility. However, it is possible that Ago2
modulates pre-rRNA processing via the RISC pathway
(see below).
Although strong accumulation of pre-5.8S rRNA was
observed in Drosha- or Dicer-depleted cells, the process-
ing defect does not appear to be severe, since the levels of
mature rRNAs were not affected. This is consistent with
the observation from a previous study, which showed that
the level of mature rRNAs was not changed in Drosha
deﬁcient mouse T cells (38). Thus, the processing steps
impaired by depletion of Drosha or Dicer may not be
essential, and production of 5.8S rRNA can be achieved
through unknown, alternative processing pathways, which
often occur during pre-rRNA processing (8,39,40).
Another possibility is that Drosha and Dicer may be
required for degradation of excess amounts of
pre-rRNA species. Depletion of these proteins then
could lead to accumulation of different precursors that
otherwise are normally degraded.
Despite the fact that multiple endonucleolytic cleavage
sites in pre-rRNA have been identiﬁed, only the MRP
complex and Rnt1 have been identiﬁed as endonucleases
responsible for certain cleavage reactions (8,15). Here, we
found that loss of Drosha and Dicer in human cells leads
to accumulation of pre-5.8S rRNA species containing ex-
tensions at 50,3 0 or both ends. In addition, Dicer is able to
cleave pre-rRNA in vitro to produce distinct products,
suggesting the existence of Dicer preferred cleavage sites/
structures (Supplementary Figure S8). However, the two
RNase III proteins appear not to be directly required for
normal endonucleolytic cleavages of pre-rRNA, since
no reduction of normal cleavage products was observed
in Dicer- or Drosha-depleted cells (Figure 3), and pre-
rRNA processing is not fully blocked by loss of these
proteins. Thus, if Drosha and Dicer are involved in
cleavage of pre-rRNA, upon depletion, other endonucle-
ase(s) must compensate for the loss of these proteins,
resulting in a sub-optimal kinetics with a slower process-
ing rate. It is also possible that the presence of Drosha
and Dicer alters the conformation of pre-rRNA, directly
or indirectly, to facilitate the activities of enzymes abso-
lutely required for pre-rRNA processing. Finally, we
cannot completely rule out the possibility that the
pre-rRNA processing detects are caused by impaired
RISC pathway that misregulated other protein factor(s)
required for pre-rRNA processing. Determining the
underlying mechanisms remains a challenge for future
studies.
The ﬁnding that loss of Ago2 moderately impairs
pre-rRNA processing is interesting. We showed that the
weaker defect in Ago2-depleted cells than in Dicer- or
Drosha-depleted cells is not due to compensatory effects
of other Ago proteins. The processing defects mimic those
caused by loss of the exosome components, leading to
accumulation of pre-5.8S rRNAs containing 30 extensions
only. Thus, it is possible that depletion of Ago2 may inter-
fere with the function of the exosome, for example, by
altering the structure of pre-ribosome thus changing the
accessibility to the exosome. On the other hand, the in-
volvement of Ago2 in pre-rRNA processing may be
mediated by miRNAs (RISC pathway), which can either
regulate gene(s) required for pre-rRNA processing, or
directly regulate pre-rRNA processing. Recent studies
have identiﬁed miRNAs in the nucleolus in rat cells with
Nucleic Acids Research, 2011,Vol.39, No. 11 4887unknown function (34,41), and at least one miRNA
(miRNA-206) was found to localize in the nucleolus, es-
pecially the granular center, where late stage of pre-rRNA
processing occurs (42). Interestingly, we found that 62 po-
tential miRNA interaction sites exist in the 50 400nt
sequence of human ITS2 (data not shown). Thus, it
remains an interesting question as whether some of these
miRNAs modulate pre-rRNA processing.
Although Dicer and Ago2 are generally believed to be
cytoplasmic proteins, here we showed that these two
proteins can be clearly detected in both cytoplasmic and
nuclear fractions in HeLa cells. This nuclear localization is
consistent with their potential involvements in pre-rRNA
processing. Nuclear localization of Dicer has been
proposed in a previous study based on immunoﬂuores-
cence staining (43), and the nuclear functions of Ago
proteins (RISC) have been demonstrated in various or-
ganisms, including fungi, plants, Drosophila and
Caenorhabditis elegans (44). Recent studies also showed
nuclear functions of the RISC pathway in mammals.
For example, the nuclear RNAs, 7SK RNA and U6,
can be down-regulated by siRNAs in human cells (45),
suggesting that Ago2, the cleavage competent Ago
protein in mammals, is present in the nucleus. Indeed,
two recent studies have shown that Ago2 was evenly
distributed between the cytoplasm and nucleus in human
cells, as detected by immunoﬂuorescence (28,46). Based on
the fact that biogenesis of most RNAs takes place in
the nucleus, the nuclear localization of these RISC
pathway proteins may imply their additional functions.
Determining the potential roles of RISC pathway in the
metabolism of other types of RNAs remains intriguing
questions for future studies.
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